​

Zoetis (ZTS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZTS Stock Forecast

Zoetis (ZTS) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $204.00, with a high of $243.00 and a low of $165.00. This represents a 39.00% increase from the last price of $146.76.

$145 $165 $185 $205 $225 $245 High: $243 Avg: $204 Low: $165 Last Closed Price: $146.76

ZTS Stock Rating

Zoetis stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 1 Strong Buy (3.45%), 17 Buy (58.62%), 11 Hold (37.93%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 29 11 17 1 Strong Sell Sell Hold Buy Strong Buy

ZTS Price Target Upside V Benchmarks

TypeNameUpside
StockZoetis39.00%
SectorHealthcare Stocks 33.91%
IndustrySpecialty & Generic Drug Manufacturers Stocks46.81%

Price Target Trends

1M3M12M
# Anlaysts124
Avg Price Target$165.00$204.00$212.50
Last Closing Price$146.76$146.76$146.76
Upside/Downside12.43%39.00%44.79%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 254105--19
Mar, 255105--20
Feb, 255105--20
Jan, 255105--20
Dec, 245105--20
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 14, 2025Jonathan BlockStifel Nicolaus$165.00$150.839.39%12.43%
Feb 04, 2025Erin WrightMorgan Stanley$243.00$172.2441.08%65.58%
Aug 07, 2024Balaji PrasadBarclays$242.00$185.2930.61%64.90%
Aug 05, 2024Jonathan BlockStifel Nicolaus$200.00$176.3113.44%36.28%
Apr 16, 2024David WestenbergPiper Sandler$195.00$149.7730.20%32.87%
Apr 02, 2024Jonathan BlockStifel Nicolaus$195.00$167.0216.75%32.87%
Nov 15, 2022Morgan Stanley$248.00$150.2565.06%68.98%
Feb 21, 2022David SteinbergJefferies$254.00$191.3232.76%73.07%
Aug 25, 2021Jasper HellwegArgus Research$225.00$203.8610.37%53.31%
Aug 09, 2021Katie TryhaneCredit Suisse$230.00$199.1615.49%56.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 04, 2025Piper SandlerOverweightOverweighthold
Oct 11, 2024Stifel NicolausBuyBuyhold
Sep 20, 2024William BlairMarket PerformMarket Performhold
Sep 18, 2024Stifel NicolausBuyBuyhold
Aug 14, 2024Piper SandlerOverweightOverweighthold
Aug 07, 2024BarclaysOverweightOverweighthold
Jul 25, 2024BTIGBuyinitialise
Apr 16, 2024Piper SandlerOverweightOverweighthold
Apr 12, 2024William BlairOutperformOutperformhold
Feb 13, 2024William BlairOutperformOutperformhold

Financial Forecast

EPS Forecast

$3 $4 $5 $6 $7 $8 $9 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.44$4.29$4.51$5.08$5.47----
Avg Forecast$3.80$4.67$4.88$5.41$5.89$6.36$7.06$7.90$8.55
High Forecast$3.86$4.75$4.99$5.43$5.93$6.50$7.42$8.11$8.81
Low Forecast$3.74$4.59$4.77$5.39$5.88$6.20$6.37$7.51$8.26
Surprise %-9.47%-8.14%-7.58%-6.10%-7.13%----

Revenue Forecast

$7B $8B $9B $10B $11B $12B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.67B$7.78B$8.08B$8.54B$9.26B----
Avg Forecast$6.60B$7.74B$8.04B$8.52B$9.26B$9.66B$10.33B$11.03B$11.44B
High Forecast$6.69B$7.85B$8.18B$8.54B$9.27B$9.83B$10.35B$11.03B$11.71B
Low Forecast$6.52B$7.65B$7.90B$8.50B$9.23B$9.45B$10.31B$11.03B$11.14B
Surprise %1.14%0.42%0.47%0.25%-0.05%----

Net Income Forecast

$1B $2B $2B $3B $4B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.64B$2.04B$2.11B$2.34B$2.49B----
Avg Forecast$1.33B$1.77B$2.01B$2.34B$2.73B$2.94B$3.05B$3.61B$3.95B
High Forecast$1.60B$2.12B$2.42B$2.81B$2.74B$3.01B$3.43B$3.75B$4.07B
Low Forecast$1.07B$1.41B$1.61B$1.88B$2.72B$2.87B$2.94B$3.47B$3.82B
Surprise %22.76%15.25%5.02%--8.87%----

ZTS Forecast FAQ

Is Zoetis stock a buy?

Zoetis stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 17 Buy, 11 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Zoetis is a favorable investment for most analysts.

What is Zoetis's price target?

Zoetis's price target, set by 29 Wall Street analysts, averages $204 over the next 12 months. The price target range spans from $165 at the low end to $243 at the high end, suggesting a potential 39.00% change from the previous closing price of $146.76.

How does Zoetis stock forecast compare to its benchmarks?

Zoetis's stock forecast shows a 39.00% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and underperforming the specialty & generic drug manufacturers stocks industry (46.81%).

What is the breakdown of analyst ratings for Zoetis over the past three months?

  • April 2025: 21.05% Strong Buy, 52.63% Buy, 26.32% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Zoetis’s EPS forecast?

Zoetis's average annual EPS forecast for its fiscal year ending in December 2025 is $6.36, marking a 16.27% increase from the reported $5.47 in 2024. Estimates for the following years are $7.06 in 2026, $7.9 in 2027, and $8.55 in 2028.

What is Zoetis’s revenue forecast?

Zoetis's average annual revenue forecast for its fiscal year ending in December 2025 is $9.66B, reflecting a 4.39% increase from the reported $9.26B in 2024. The forecast for 2026 is $10.33B, followed by $11.03B for 2027, and $11.44B for 2028.

What is Zoetis’s net income forecast?

Zoetis's net income forecast for the fiscal year ending in December 2025 stands at $2.94B, representing an 18.14% increase from the reported $2.49B in 2024. Projections indicate $3.05B in 2026, $3.61B in 2027, and $3.95B in 2028.